JENNIFER MEYER: Open Payments
NPI 1588035117 · LAKEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,101 in 91 payments from 18 companies in 2025. Trend: 2023 $2,025 · 2024 $2,249 · 2025 $2,101
Food & beverage: $2,101
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $476 |
| Gilead Sciences, Inc. | 12 | $346 |
| Janssen Biotech, Inc. | 8 | $284 |
| PFIZER INC. | 8 | $132 |
| GENZYME CORPORATION | 6 | $123 |
| Ipsen Biopharmaceuticals, Inc | 5 | $112 |
| Regeneron Healthcare Solutions, Inc. | 5 | $100 |
| Ardelyx, Inc. | 4 | $95 |
| Phathom Pharmaceuticals, Inc. | 3 | $69 |
| Lilly USA, LLC | 4 | $68 |
Products named: TREMFYA, DUPIXENT, CREON, RINVOQ, IQIRVO, XELJANZ, IBSRELA, VOQUEZNA.
Industry payments across CO — which companies pay providers there.
